JAMA editors' list of top research for 2025 includes studies on GLP-1 drugs and heart failure, the shingles vaccine and ...

Like everything in health policy, it's complicated.

"What you have said is a terrible, terrible distortion of all the facts." -- CDC Advisory Committee on Immunization Practices ...

Today, we confront emerging threats from a range of respiratory viruses, insect-transmitted viruses, and viruses we have not ...

Kotsopoulos noted that BRCA carriers have a substantially increased lifetime risk of breast and ovarian cancer. Management of ...

In May 2018, andexanet was granted accelerated approval as the sole antidote on the market for the DOACs rivaroxaban (Xarelto ...

Use of the dual GIP/GLP-1 drug tirzepatide (Mounjaro, Zepbound) was associated with a significantly reduced risk of glaucoma ...

Helen Tager-Flusberg, PhD, director of the Center for Autism Research Excellence at Boston University, said Johnson has ...

The FDA on Thursday approved a transcranial direct current stimulation (tDCS) device as the first at-home non-drug therapy ...

In an appearance on "The Late Show With Stephen Colbert" on Wednesday night, Taylor Swift described how fans who attended ...

Six-time Olympic cycling champion Chris Hoy's prostate cancer diagnosis, revealed in 2023, put the disease under the ...